Recent Finacing
Recent Raise
Dewpoint Therapeutics develops condensate‑modulating small molecules using an AI/ML‑driven, high‑throughput platform to detect and modulate biomolecular condensates across oncology, neurodegenerative, cardiopulmonary, metabolic, and virology indications.
